Terri Hunter

654 total citations
8 papers, 541 citations indexed

About

Terri Hunter is a scholar working on Immunology, Oncology and Biotechnology. According to data from OpenAlex, Terri Hunter has authored 8 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Oncology and 2 papers in Biotechnology. Recurrent topics in Terri Hunter's work include Immunotherapy and Immune Responses (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and CAR-T cell therapy research (3 papers). Terri Hunter is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and CAR-T cell therapy research (3 papers). Terri Hunter collaborates with scholars based in United States and France. Terri Hunter's co-authors include Scott Antonia, Dmitry I. Gabrilovich, Rupal Ramakrishnan, Srinivas Nagaraj, Hyun-Il Cho, Esteban Celis, Soner Altiok, Deepak Assudani, Marwan Alsarraj and David Noyes and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Journal of Surgical Research.

In The Last Decade

Terri Hunter

7 papers receiving 535 citations

Peers

Terri Hunter

ONCOL

IMMUN

MB

PRM

BE

Houssein Abdul Sater United States

M.T. Spiotto United States

Arnold Baars Netherlands

Harshini Chinnasamy United States

Sjoerd van der Burg Netherlands

Qiu‐Xia Qu China

Tomáš Brtnický Czechia

Sheri McMahon United States

Annika De Sousa Linhares Austria

Hidetoshi Nakagawa Japan

Houssein Abdul Sater United States

Terri Hunter

373 ×1.0

ONCOL

298 ×0.8

IMMUN

122 ×1.2

MB

81 ×1.3

PRM

21 ×0.6

BE

Citations per year, relative to Terri Hunter Terri Hunter (= 1×) peers Houssein Abdul Sater

Countries citing papers authored by Terri Hunter

Since Specialization

Citations

This map shows the geographic impact of Terri Hunter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terri Hunter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terri Hunter more than expected).

Fields of papers citing papers by Terri Hunter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terri Hunter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terri Hunter. The network helps show where Terri Hunter may publish in the future.

Co-authorship network of co-authors of Terri Hunter

This figure shows the co-authorship network connecting the top 25 collaborators of Terri Hunter. A scholar is included among the top collaborators of Terri Hunter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terri Hunter. Terri Hunter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Creelan, Ben, Scott Antonia, David Noyes, et al.. (2013). Phase II Trial of a GM-CSF-producing and CD40L-expressing Bystander Cell Line Combined With an Allogeneic Tumor Cell–based Vaccine for Refractory Lung Adenocarcinoma. Journal of Immunotherapy. 36(8). 442–450. 28 indexed citations

2.

Creelan, Ben, Scott Antonia, David Noyes, et al.. (2012). Phase II trial of a GM-CSF-producing and CD40L-expressing cell line combined with allogeneic tumor antigen as a novel vaccine for metastatic lung adenocarcinoma.. Journal of Clinical Oncology. 30(15_suppl). 2559–2559.

3.

Hunter, Terri, et al.. (2011). Paclitaxel and TRAIL synergize to kill paclitaxel-resistant small cell lung cancer cells through a caspase-independent mechanism mediated through AIF.. PubMed. 31(10). 3193–204. 28 indexed citations

4.

Ramakrishnan, Rupal, Deepak Assudani, Srinivas Nagaraj, et al.. (2010). Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice. Journal of Clinical Investigation. 120(4). 1111–1124. 382 indexed citations

5.

Fishman, Mayer, Terri Hunter, Hatem Soliman, et al.. (2008). Phase II Trial of B7-1 (CD-86) Transduced, Cultured Autologous Tumor Cell Vaccine Plus Subcutaneous Interleukin-2 for Treatment of Stage IV Renal Cell Carcinoma. Journal of Immunotherapy. 31(1). 72–80. 52 indexed citations

6.

Hunter, Terri, Marwan Alsarraj, Ronald P. Gladue, Vahe Bedian, & Scott Antonia. (2007). An Agonist Antibody Specific for CD40 Induces Dendritic Cell Maturation and Promotes Autologous Anti‐tumour T‐cell Responses in an In vitro Mixed Autologous Tumour Cell/Lymph Node Cell Model. Scandinavian Journal of Immunology. 65(5). 479–486. 34 indexed citations

7.

Hunter, Terri, Ronald P. Gladue, & Scott Antonia. (2006). An anti-CD40 activating antibody induces dendritic cell maturation and promotes autologous anti-tumor T cell responses in an in vitro mixed autologous tumor cell/lymph node cell model. Journal of Clinical Oncology. 24(18_suppl). 2537–2537. 1 indexed citations

8.

Dessureault, Sophie, Marwan Alsarraj, Susan McCarthy, et al.. (2005). A GM-CSF/CD40L Producing Cell Augments Anti-tumor T Cell Responses. Journal of Surgical Research. 125(2). 173–181. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact